Impact of cyclic citrullinated peptide antibody level on progression to rheumatoid arthritis in clinically tested cyclic citrullinated peptide antibody–positive patients …

JA Ford, X Liu, AA Marshall, A Zaccardelli… - Arthritis care & …, 2019 - Wiley Online Library
Objective To investigate the risk of progression to rheumatoid arthritis (RA) in patients who
were cyclic citrullinated peptide (CCP) antibody positive without RA at initial presentation …

Th9 lymphocytes: a recent history from IL-9 to its potential role in rheumatic diseases

WG Rojas-Zuleta, G Vásquez - Autoimmunity reviews, 2016 - Elsevier
Various subtypes of effector T cells have been described up to date, and each one has its
specific immunological function and a defined cytokine secretion profile. Th9 lymphocytes …

Prediction of future rheumatoid arthritis

SA Turk, MH van Beers-Tas… - Rheumatic Disease …, 2014 - rheumatic.theclinics.com
Methods We searched the PubMed database on January 29, 2014, for the terms risk,
prediction, and development in relation to RA. After excluding articles not directly related to …

Beneficial Effect of Toxoplasma gondii Infection on the Prognosis of Breast Cancer Was Modified by Cytokines

HM Ye, MJ Lu, Q Liu, Y Lin, LY Tang… - Clinical Epidemiology, 2023 - Taylor & Francis
Background Animal experiments have shown the anticancer activity of Toxoplasma gondii
(T. gondii), but its effect on the prognosis of cancer patients is unclear. Thus, the present …

Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review

M Khokhar, S Dey, S Tomo, M Jaremko… - ACS Pharmacology & …, 2024 - ACS Publications
Rheumatoid arthritis (RA) is a chronic debilitating autoimmune disease, that causes joint
damage, deformities, and decreased functionality. In addition, RA can also impact organs …

Circulating miR-10a as predictor of therapy response in rheumatoid arthritis patients treated with methotrexate

H Hong, H Yang, Y Xia - Current pharmaceutical biotechnology, 2018 - ingentaconnect.com
Background: Anti-inflammatory drugs and DMARDs, especially methotrexate, have
dramatically improved the outlook of RA patient. However, in some patients the treatment …

Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis

A Lagha, S Zidi, M Stayoussef, E Gazouani… - Pathologie …, 2015 - Elsevier
Objectives The aim of this study was to investigate the role of IL-1β (− 511C> T), TNFα (-308
G> A), IL-10 (-1082 G> A) and IL-1RN VNTR polymorphisms in the susceptibility to …

[HTML][HTML] Diagnosis and natural history of preclinical and early inflammatory bowel disease

I Rodríguez-Lago, Y Zabana… - Annals of …, 2020 - ncbi.nlm.nih.gov
Inflammatory bowel disease is a chronic and progressive disorder of the gastrointestinal
tract. A relevant proportion of patients develop complicated lesions, defined as strictures …

The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states

M Khokhar, P Purohit - International Reviews of Immunology, 2024 - Taylor & Francis
Th9 cells, a subset of T-helper cells producing interleukin-9 (IL-9), play a vital role in the
adaptive immune response and have diverse effects in different diseases. Regulated by …

Th 9 cells in Behçet disease: Possible involvement of IL-9 in pulmonary manifestations

W Kaabachi, M Khaouthar, B Hamdi, I Khalfallah… - Immunology …, 2019 - Elsevier
Behçet disease (BD) is a multisystemic disease some of whose manifestations are
characterized by pulmonary involvements. The purpose of the study was to evaluate the …